To date, 32 anti-HIV medicines have been authorised in the EU on the recommendation of the Agency. The Agency has also recommended the authorisation of medicines used to treat infections and cancers in patients with AIDS, and stimulates research into medicines for HIV and AIDS in children.
The Agency has given opinions on three anti-HIV medicines for use exclusively in markets outside the EU. These opinions are given in co-operation with the World Health OrganizationExternal link icon (WHO) for diseases of major public-health interest.
The Agency works closely with organisations representing patients with HIV and AIDS through the European AIDS Treatment GroupExternal link icon (EATG), a patient-led group advocating for HIV/AIDS treatment and good quality of life. It also interacts with organisations representing healthcare professionals through the European AIDS Clinical SocietyExternal link icon (EACS).
The Agency also produces guidelines for companies developing medicines for use in people with HIV. This year, it carried out a public consultation on a reflection paper on the use of medicines to prevent the transmission of HIV for public consultation. The outcome of this consultation will be published in early 2013.